May statins and PCSK9 inhibitors be protective from COVID-19 in familial hypercholesterolemia subjects?

Scicali, Roberto; Di Pino, Antonino; Piro, Salvatore; Rabuazzo, Agata M; Purrello, Francesco

Scicali, Roberto; Di Pino, Antonino; Piro, Salvatore; Rabuazzo, Agata M; Purrello, Francesco.

Scicali R; Department of Clinical and Experimental Medicine, University of Catania, Italy.
Di Pino A; Department of Clinical and Experimental Medicine, University of Catania, Italy.
Piro S; Department of Clinical and Experimental Medicine, University of Catania, Italy.
Rabuazzo AM; Department of Clinical and Experimental Medicine, University of Catania, Italy.
Purrello F; Department of Clinical and Experimental Medicine, University of Catania, Italy. Electronic address: fpurrell@unict.it.

Nutr Metab Cardiovasc Dis ; 30(7): 1068-1069, 2020 06 25.

Article in English | MEDLINE | ID: covidwho-244971

Subject(s)

Coronavirus Infections/epidemiology; Coronavirus Infections/prevention & control; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use; Hyperlipoproteinemia Type II/drug therapy; Hyperlipoproteinemia Type II/epidemiology; Pandemics/prevention & control; Pneumonia, Viral/epidemiology; Pneumonia, Viral/prevention & control; Proprotein Convertase 9/drug effects; Adult; Age Factors; COVID-19; Cause of Death; China; Comorbidity; Female; Humans; Hyperlipoproteinemia Type II/diagnosis; Incidence; Male; Middle Aged; Pandemics/statistics & numerical data; Prognosis; Proprotein Convertase 9/genetics; Proprotein Convertase 9/therapeutic use; Risk Assessment; Sex Factors; Survival Analysis; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Pandemics / Proprotein Convertase 9 / Hyperlipoproteinemia Type II Type of study: Diagnostic study / Observational study / Prognostic study Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: English Journal: Nutr Metab Cardiovasc Dis Journal subject: Vascular Diseases / Cardiology / Nutritional Sciences / Metabolism Year: 2020 Document Type: Article Affiliation country: J.numecd.2020.05.003

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google